Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-25
2005-10-25
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S439000, C514S443000, C514S380000, C514S407000, C514S411000, C514S414000, C546S135000, C548S190000, C548S206000, C548S233000, C548S245000, C548S427000
Reexamination Certificate
active
06958348
ABSTRACT:
Disclosed is an anti-cancer compound represented by Structural Formula (I):The variables in Structural Formula (I) are described hereinbelow. Also disclosed is a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by Structural Formula (I) (preferably an effective amount). Also disclosed is a method of treating a subject with cancer by administering to the subject an effective amount of a compound represented by Structural Formula (I).
REFERENCES:
patent: 5965582 (1999-10-01), Lebaut et al.
patent: 6008231 (1999-12-01), Lebaut et al.
patent: 6232327 (2001-05-01), Nickel et al.
patent: 6344467 (2002-02-01), Lebaut et al.
patent: 6500853 (2002-12-01), Seehra et al.
patent: 2003/0181482 (2003-09-01), Chen et al.
patent: 2004/0029858 (2004-02-01), Menta et al.
patent: 1157704 (2001-11-01), None
patent: 9943654 (1998-02-01), None
patent: WO 99/43654 (1999-09-01), None
patent: WO 99/51224 (1999-10-01), None
patent: WO 00/26202 (2000-05-01), None
patent: WO 00/67802 (2000-11-01), None
patent: WO 00/71535 (2000-11-01), None
patent: WO 02/08225 (2002-01-01), None
patent: WO 02/10152 (2002-02-01), None
Patani et. al., “Bioisosterism: A Rational Approach in Drug Design”, Chem. Rev. 1996, 96, pp. 3147-3176.
See Ca 131:199619, “Preparation of indole derivatives as phospholipase enzyme inhibitors”, Seehra. et al.
James David
Koya Keizo
Li Hao
Liang Guiqing
Ono Mitsunori
Hamilton Brook Smith & Reynolds PC
Saeed Kamal A.
Synta Pharmaceuticals Corp.
LandOfFree
3-glyoxylamideindoles for treating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-glyoxylamideindoles for treating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-glyoxylamideindoles for treating cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3436366